Last reviewed · How we verify
NCT04550013
Blood Flow Restriction Training for Treatment of Chronic Patellar Tendinopathy
NA trial testing Heavy-Slow Resistance training in Patellar Tendinopathy in 36 participants. Status unknown.
30 December 2022
Quick facts
| Lead sponsor | Bispebjerg Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 36 |
| Start date | 1 August 2020 |
| Primary completion | 30 December 2022 |
| Estimated completion | 23 September 2023 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Heavy-Slow Resistance training
- Low-Load Blood Flow Restriction training
Conditions studied
- Patellar Tendinopathy — all drugs for Patellar Tendinopathy →
- Jumper's Knee — all drugs for Jumper's Knee →
Sponsor
Bispebjerg Hospital
Who can join
Adults 18 to 70, male only, with Patellar Tendinopathy or Jumper's Knee. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to investigate the clinical and functional outcome of a 12-week rehabilitation regime consisting of Low-Load Blood Flow Restriction compared to Heavy-Slow Resistance training in male patients with chronic unilateral patellar tendinopathy.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Assessment of the Psychometric Properties of the Danish VISA-P.
Agergaard AS, Comins JD, Siersma V, Malmgaard-Clausen NM, et al · · 2023 · cited 2× · PMID 38654908 · DOI 10.1155/2023/5291949 -
Effect of Low-Load Blood-Flow Restricted Training Versus Heavy Slow Resistance Training in Unilateral Patellar Tendinopathy: A Randomized Clinical Trial.
Hjortshoej MH, Juneja H, Svensson RB, Herzog RB, et al · · 2025 · cited 1× · PMID 41452311 · DOI 10.1111/sms.70186 -
Application of multispectral optoacoustic tomography for lower limb musculoskeletal sports injuries in adults.
Svensson RB, Agergaard AS, Sardella T, Reichl C, et al · · 2024 · cited 1× · PMID 40017825 · DOI 10.1016/j.pacs.2024.100656
Verify or expand the search:
- PubMed search for NCT04550013
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Patellar Tendinopathy
Currently open trials in the same condition.
- NCT06705881 — Efficacy of the Extracorporeal Shock Wave Therapy in Athletes With Patellar Tendinopathy · NA · recruiting
- NCT06729437 — Transcranial Direct Current Stimulation on Functionality and Pain in Individuals with Patellar Tendinopathy · NA · recruiting
- NCT05407194 — Effect of Collagen/Vitamin C in Jumper's Knee; a RCT · NA · recruiting
- NCT05731037 — Influence of Restitution Time in Treatment of Patellar Tendinopathy · NA · active not recruiting
Other Bispebjerg Hospital trials
Trials by the same sponsor.
- NCT06872060 — The Effects of Glucagon on Renal Regional Blood Flow in Humans Measured by Magnetic Resonance. · NA · not yet recruiting
- NCT07373587 — Preventing Hospital Associated Disability in Older Patients: Individualized Nutrition and Exercise Strategy · NA · not yet recruiting
- NCT07123558 — Anal Cancer Prevention in High-Risk Categories of Men Who Have Sex With Men · NA · not yet recruiting
- NCT07124338 — Preventing Hospital Associated Disability in Older Patients: Individualized Nutrition and Exercise Strategy, a Feasibili · NA · active not recruiting
- NCT07096648 — Alert Burden When Monitoring Patients at Home · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04550013 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bispebjerg Hospital
- Last refreshed: 18 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04550013.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing